← Back
$CRBP All transactions

Corbus Pharmaceuticals Holdings, Inc.

▼ SELL 10b5-1 Plan

$ Value

$108K

Shares

13,871

Price

$8

Filed

Feb 18

Insider

Name

Cohen Yuval

Title

Chief Executive Officer

CIK

0001626003

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

174,316

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.58 to $7.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | This amount includes 138,049 unvested RSUs subject to each grant's vesting schedule as previously reported.

Filing Info

Accession No.

0001193125-26-057159

Form Type

4

Issuer CIK

0001595097

Cohen Yuval's History

Date Ticker Type Value
2026-02-13 CRBP $108K
2026-01-14 CRBP A $0
2026-01-14 CRBP A $0
2025-10-27 CRBP M $38K
2025-10-27 CRBP $154K
2025-10-27 CRBP M $0
2025-10-24 CRBP M $79K
2025-10-24 CRBP $317K
2025-10-24 CRBP M $0

Other Insiders at CRBP (90d)

Insider Bought Sold Last
Moran Sean F.
Chief Financial Officer
$37K 2026-02-13
Smethurst Dominic
Chief Medical Officer
$77K 2026-03-02
Hodgson Ian
Chief Operating Officer
$26K 2026-02-17